MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at HC Wainwright in a note issued to investors on Monday, Benzinga reports. They presently have a $75.00 price target on the stock. HC Wainwright’s price target suggests a potential upside of 30.78% from the stock’s previous close. Several […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the ten research firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and nine have given a buy rating to the company. The average 12-month price target among brokers […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) had its price target increased by Wedbush from $61.00 to $86.00 in a research report report published on Monday, Marketbeat Ratings reports. Wedbush currently has an outperform rating on the stock. Wedbush also issued estimates for MoonLake Immunotherapeutics’ Q3 2023 earnings at ($0.17) EPS, Q4 2023 earnings at ($0.17) […]
MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Buy Rating from HC Wainwright themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
MoonLake Immunotherapeutics (NASDAQ:MLTX) Trading Up 6 1% kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.